4:03 PM ET
8-K
Shareholder Meeting
Phio Pharmaceuticals Shareholder Meeting
Phio Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 28, 2026, where shareholders elected six directors and ratified Grant Thornton, LLP as the independent auditor. Stockholders also approved an amendment to the 2020 Long Term Incentive Plan, increasing the number of shares available for issuance by 1,500,000 shares.